These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1487 related articles for article (PubMed ID: 21231796)
1. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579 [TBL] [Abstract][Full Text] [Related]
3. Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Uttam M; Pravin N; Anish B; Nandita K; Arup M Int Braz J Urol; 2016; 42(2):234-41. PubMed ID: 27256176 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037 [TBL] [Abstract][Full Text] [Related]
5. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381 [TBL] [Abstract][Full Text] [Related]
6. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ; Cho A; Yun M; Kim YT; Kang WJ Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334 [TBL] [Abstract][Full Text] [Related]
7. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817 [TBL] [Abstract][Full Text] [Related]
8. Pelvic Lymph Node Staging by Combined Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364 [TBL] [Abstract][Full Text] [Related]
9. Pilot Study of [ Eulitt PJ; Altun E; Sheikh A; Wong TZ; Woods ME; Rose TL; Wallen EM; Pruthi RS; Smith AB; Nielsen ME; Whang YE; Kim WY; Godley PA; Basch EM; David GU; Ramirez J; Deal AM; Rathmell WK; Chen RC; Bjurlin MA; Lin W; Lee JK; Milowsky MI Clin Genitourin Cancer; 2020 Oct; 18(5):378-386.e1. PubMed ID: 32147364 [TBL] [Abstract][Full Text] [Related]
10. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer]. Li H; Wu H; Wang Q; Han Y; Wang Q Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096 [TBL] [Abstract][Full Text] [Related]
12. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605 [TBL] [Abstract][Full Text] [Related]
13. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy. Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105 [TBL] [Abstract][Full Text] [Related]
15. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706 [TBL] [Abstract][Full Text] [Related]
16. FDG-PET for preoperative staging of bladder cancer. Drieskens O; Oyen R; Van Poppel H; Vankan Y; Flamen P; Mortelmans L Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1412-7. PubMed ID: 16133380 [TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma]. Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734 [TBL] [Abstract][Full Text] [Related]
18. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma. Lee HJ; Park JY; Lee JJ; Kim MH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus. Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]